COMMUNIQUÉS West-GlobeNewswire

RS BioTherapeutics Launches Crowdfunding Campaign Through StartEngine
30/04/2024
CUMBERLAND, Md., April 30, 2024 (GLOBE NEWSWIRE) -- RS BioTherapeutics, whose mission is to develop life-changing medicines for the millions of people suffering from diseases characterized by pulmonary inflammation, [...]
Resolutions of Annual Geneal Meeting
30/04/2024
April 30, 2024 Announcement no. 10 Resolutions of Annual Geneal Meeting COPENHAGEN, DENMARK and BOSTON, MA, USA, April 30, 2024, (GLOBE NEWSWIRE) -- BioPorto A/S (BioPorto or Company) (CPH:BIOPOR), an in vitro [...]
ARS Pharmaceuticals Submits Response for neffy® (epinephrine nasal spray) Marketing Authorization Application to EMA’s CHMP and Enters License Agreement with CSL Seqirus for Commercialization of neffy in Australia and New Zealand
30/04/2024
CHMP opinion on neffy Marketing Authorization Application anticipated in the second quarter of 2024 Response addresses all issues previously identified by CHMP, and includes results from a repeat dose PK/PD study of [...]
Nicklaus Children’s Health System, Philips to provide innovative patient and staff experience, helping to enhance outcomes for the smallest of patients
30/04/2024
April 30, 2024 Philips AI-enabled diagnostic and experiential technologies help put patients at ease while empowering staff with faster, high-quality scans and increased diagnostic confidence Amsterdam, the Netherlands [...]
WeightWatchers Hosts ‘Making The Shift: A New Way to Think About Weight,’ A Live Virtual Event with Oprah Winfrey on Thursday, May 9
30/04/2024
Special guests include Rebel Wilson, Katie Sturino, Amber Riley, Marisa Meltzer, Jamie Kern Lima, Tressie McMillan Cottom, and leading medical and science experts Dr. Rachel Goldman and Dr. Ania Jastreboff NEW YORK, [...]
Kamari Pharma Appoints Dr. John Doux to its Board of Directors
30/04/2024
NESS ZIONA, Israel, April 30, 2024 (GLOBE NEWSWIRE) -- Kamari Pharma , a privately-held clinical stage biotechnology company developing first and best-in-class treatments for rare and severe genetic skin diseases, today [...]
Visory Health Teams Up with the Miami Dolphins to Increase Access to Affordable Healthcare for South Florida through Health in the Hood Community Outreach Event
30/04/2024
As the official prescription discount card of the Miami Dolphins, the two organizations provided free resources to underserved communities in the Miami-Dade area ESTERO, Fla., April 30, 2024 (GLOBE NEWSWIRE) -- Visory [...]
Discovery Therapeutics Caribe Receives Study May Proceed Letter from FDA to initiate a Phase 3 Clinical Trial of intralesional rhEGF for the treatment of diabetic foot ulcers
30/04/2024
CLEVELAND, April 30, 2024 (GLOBE NEWSWIRE) -- Discovery Therapeutics Caribe (DTC), a clinical-stage biotechnology company dedicated to improving the health outcomes of Americans through the development of regenerative [...]
Beacon Biosignals and Takeda Launch Strategic Collaboration to Advance Neurobiomarkers and Endpoints for Sleep Disorders
30/04/2024
Collaboration leverages Beacon’s FDA-cleared at-home EEG headband and artificial intelligence platform to support development of novel precision therapies and improve the diagnostic journey for patients BOSTON, April 30 [...]
OneMedNet Joins ClinEco Community of Clinical Research Industry Members
30/04/2024
~ Validates OneMedNet’s Regulatory Grade Real World Data Platform Among the Clinical Trial Eco-System ~ MINNEAPOLIS, April 30, 2024 (GLOBE NEWSWIRE) -- OneMedNet Corporation (Nasdaq: ONMD) (“OneMedNet”), the leading [...]
Nacuity Pharmaceuticals Announces First Patients Implanted in Final Cohort of Phase 1/2 Clinical Trial Evaluating NPI-002 Intravitreal Implant for the Delay of Cataract Progression
30/04/2024
Two patients have been implanted in the final cohort of the trial Final cohort is actively enrolling adult patients undergoing vitrectomy FORT WORTH, Texas, April 30, 2024 (GLOBE NEWSWIRE) -- Nacuity Pharmaceuticals, [...]
CERo Therapeutics, Inc. Presents Encouraging Preclinical Data for AML on CER-1236 at Stanford Drug Discovery Symposium Highlighting Tumor Elimination and Manufacturing Attributes
30/04/2024
SOUTH SAN FRANCISCO, Calif., April 30, 2024 (GLOBE NEWSWIRE) -- CERo Therapeutics Holdings, Inc., (NASDAQ:CERO) (“CERo”) an innovative immunotherapy company seeking to advance the next generation of engineered T cell [...]
ALX Oncology Announces Initiation of Phase 2 Investigator-Sponsored Trial of Neoadjuvant Radiation and Evorpacept in Combination with Pembrolizumab in Patients with Untreated HPV-Mediated Oropharyngeal Cancer
30/04/2024
SOUTH SAN FRANCISCO, Calif., April 30, 2024 (GLOBE NEWSWIRE) -- ALX Oncology Holdings Inc., (“ALX Oncology” or “the Company”) (Nasdaq: ALXO), an immuno-oncology company developing therapies that block the CD47 immune [...]
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia
30/04/2024
Cannabix is developing alcohol and marijuana breathalyzer devices to give law enforcement and employers a tool to enhance public safety VANCOUVER, British Columbia, April 30, 2024 (GLOBE NEWSWIRE) -- Cannabix [...]
Fractyl Health Announces Multiple Presentations at the Upcoming Digestive Disease Week (DDW) 2024 Conference and the German Diabetes Association (DDG) Annual Meeting
30/04/2024
At DDG, Fractyl Health will present new clinical updates on its ongoing real-world registry study of Revita ® in patients with T2D in Germany At DDW, Fractyl Health will provide an oral presentation from its Rejuva ® [...]
Wave Life Sciences Announces Approval of First Clinical Trial Application for RestorAATion-2 Trial of WVE-006 in Individuals with Alpha-1 Antitrypsin Deficiency (AATD)
30/04/2024
Proof-of-mechanism data for WVE-006 in individuals with AATD remain on track for 2024 CAMBRIDGE, Mass., April 30, 2024 (GLOBE NEWSWIRE) -- Wave Life Sciences Ltd. (Nasdaq: WVE), a clinical-stage biotechnology company [...]
Veru Enrolls First Patients in Phase 2b Clinical Trial of Enobosarm and Semaglutide Combination for High Quality Weight Loss
30/04/2024
-- The Phase 2b study planned to be conducted in 15 clinical sites in the United States -- -- Topline clinical data expected in the fourth quarter calendar year 2024 -- MIAMI, FL, April 30, 2024 (GLOBE NEWSWIRE) -- Veru [...]
Orchestra BioMed Announces AVIM Therapy Global Intellectual Property Estate Reaches 110 Issued Patents
30/04/2024
Patent estate covering atrioventricular interval modulation (“AVIM”) therapy includes 37 issued U.S. patents and 73 patents outside the U.S. that collectively comprise over 1,800 claims related to the treatment of [...]
SeaStar Medical Announces $3.6 Million NIH Grant Award to Study the Selective Cytopheretic Device in Adult Patients with Severe Chronic Heart Failure
30/04/2024
DENVER, April 30, 2024 (GLOBE NEWSWIRE) -- SeaStar Medical Holding Corporation (Nasdaq: ICU), a medical device company developing proprietary solutions to reduce the consequences of hyperinflammation on vital organs, [...]

Pages